Skip to main content

Table 2 Concentrations of immune parameters and monocyte markers in TS and healthy controls

From: Altered monocyte activation markers in Tourette’s syndrome: a case–control study

Variable

Group

Mean ± SD

Rank sum

z-value

p-value*

Monocytes/nl

Patients

0.57 ± 0.22

50.1

−2.152

0.031

 

Controls

0.47 ± 0.11

38.37

  

TNF-alpha pg/ml

Patients

0.43 ± 0.18

33.09

−2.421

0.015

 

Controls

0.56 ± 0.25

45.39

  

IL-6 pg/ml

Patients

1.89 ± 1.71

39.41

−1.215

n.s.

 

Controls

1,74 ± 1,64

33.43

  

IL1-ra ng/ml

Patients

0.03 ± 0.09

36.11

−2.813

0.005

 

Controls

0.04 ± 0.06

51.24

  

sCD14 ng/ml

Patients

6.37 ± 1.43

30.25

−4.934

<0.0001

 

Controls

8.40 ± 2.00

56,68

  

CRP mg/dl

Patients

0.43 ± 0.27

45.53

−2.013

0.044

 

Controls

0.37 ± 0.37

37.85

  

Neopterin nmol/l

Patients

6.03 ± 2.19

48.51

−2.084

0.037

 

Controls

5.19 ± 1.84

37.36

  
  1. SD = standard deviation, n.s. = not significant; *Mann–Whitney U Test.